The Department of Health and Human Services' Food and Drug Administration awarded a $149,000 firm-fixed-price purchase order to Predictive LLC, a small business limited liability company, to develop an in silico (computational) effort to understand the metal peptidome and help leverage clinical diagnostic tools. This contract was set aside for small businesses and completed in September 2021. Predictive LLC specializes in providing computational models and software to predict chemical bioactivity and toxicity as alternatives to animal testing. The FDA's requirement was for services to acquire expertise in computational modeling related to the metal peptidome, which is likely to support the agency's efforts in evaluating chemical safety and developing clinical diagnostic capabilities.
Generated 3/23/24, 2:16 AM